Cancer Research

Prostate UK Fights Prostate Cancer And More

LONDON, October 12 /PRNewswire/-- Prostate Research Campaign UK, the only UK charity fighting ALL prostate diseases, will in future be known as Prostate UK. The change of name to Prostate UK reinforces the charity's broad focus, offering not only inf ...

Article - Anna Ohlden - Oct 12 2007 - 7:13am

Immune Disease Treatment Advance: GRP94 Protein Structure Solved

Dr. Dan Gewirth, Hauptman-Woodward senior research scientist, has just solved the structure of the first mammalian GRP94 protein implicated in immune diseases such as sepsis, AIDS and certain cancers. His work is being published today in a cover article in ...

Article - News Staff - Oct 12 2007 - 8:45pm

Smoke-Free Environment Without Exceptions

BASEL, Switzerland, October 13 /PRNewswire/-- At the closing of the 4th European < > conference 2007 in Basel today, more than 500 experts from 62 countries requested effective protection against passive smoking. Smoke-free indoor areas which are ac ...

Article - Anna Ohlden - Oct 13 2007 - 9:42am

Top-Line Efficacy Data Presented From Phase 2 Trial Of Alemtuzumab In Multiple Sclerosis

CAMBRIDGE, Massachusetts, October 15 /PRNewswire/--- Three-Year Analysis Demonstrates Robust, Highly Statistically Significant Treatment Effect of Alemtuzumab Compared to Rebif(R) Genzyme Corporation (Nasdaq: GENZ) today announced that top-line, three-yea ...

Article - Anna Ohlden - Oct 15 2007 - 1:03am

Prince Harry Joins WellChild In Celebrating Brave Sick Children

CHELTENHAM, England, October 15 /PRNewswire/--- Charity Patron, Prince Harry to Meet the Winners at the 3rd WellChild and Best Magazine Children's Health Awards, 22nd October, 2007 On Monday 22nd November, Prince Harry will be attending the ceremony ...

Article - Anna Ohlden - Oct 15 2007 - 8:25am

EpiCept To Present Pre-clinical Advances Of Myc Oncogene Directed Drug Discovery At Assays And Cellular Targets Conference

TARRYTOWN, New York, October 16 /PRNewswire/-- EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that Dr. John Drewe, Senior Director of Lead Discovery, will be presenting at the IBC conference on Assays and Cellular Targets at th ...

Article - Anna Ohlden - Oct 15 2007 - 7:50pm

Post-Surgical Wound Healing: With Honey?

Honey is enjoying new advocates as a wound-healing solution amid rising concerns about antibiotic resistance and a renewed interest in natural healing. ...

Article - News Staff - Oct 17 2007 - 10:13am

T7 Endonuclease 1: The Enzyme That Makes Us Unique?

Have you ever wondered why you inherited your mother’s smile but not your father’s height? Researchers at the Universities of Leeds and Dundee are one step closer to unravelling how nature combines both maternal and paternal DNA to create genetically uniqu ...

Article - News Staff - Oct 17 2007 - 11:32am

Abbott Scientists Create One Molecule With Two Antibody Functions

ABBOTT PARK, Illinois, October 18 /PRNewswire/--- First Combination of Large Molecules to Show Drug-like Properties and Manufacturing Feasibility Abbott (NYSE: ABT) reported today that its scientists are the first to discover a proprietary technology that ...

Article - Anna Ohlden - Oct 18 2007 - 8:44am

Astex Drug Candidates To Be Featured At The 2007 AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therape

CAMBRIDGE, England, October 18 /PRNewswire/-- Astex Therapeutics Ltd. today announced that data on two of its drug candidates, AT7519 and AT13148, will be presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therap ...

Article - Anna Ohlden - Oct 18 2007 - 11:23am